| |
Univariable Cox regression analysis
|
Multivariable Cox regression analysis
|
---|
Parameters
| |
HR
|
95%CI
|
p
|
HR
|
95%CI
|
p
|
---|
Before PSM
|
Age
|
≥ 70/< 70
|
1.172
|
0.721–1.907
|
0.521
| | | |
Gender
|
F/M
|
1.045
|
0.622–1.756
|
0.867
| | | |
BMI
|
< 30/≥30
|
1.138
|
0.673–1.924
|
0.629
| | | |
Hemoglobin level
|
≤ 100/> 100
|
1.682
|
0.854–3.314
|
0.133
| | | |
Tumor location
|
Proximal, middle/Distal
|
1.608
|
0.948–2.728
|
0.078
| | | |
TNM stage (AJCC classification)
|
III, IV/ I, II
|
3.925
|
2.402–6.414
|
0.000*
|
3.519
|
2.067–5.993
|
0.000*
|
Chemotherapy
|
Yes/No
|
1.205
|
0.740–1.963
|
0.453
| | | |
Lymphadenectomy type
|
D1/D1+/D2
|
1.338
|
0.787–2.272
|
0.282
| | | |
Gastrectomy type
|
Total/Partial
|
1.803
|
1.102–2.949
|
0.019*
| | | |
aOverall complication
|
Yes/No
|
3.169
|
1.895–5.298
|
0.000*
|
2.971
|
1.714–5.149
|
0.000*
|
After PSM
|
Age
|
≥ 70/< 70
|
1.666
|
0.714–3.881
|
0.237
| | | |
Gender
|
M/F
|
1.069
|
0.416–2.744
|
0.890
| | | |
BMI
|
< 30/≥ 30
|
3.463
|
0.808–14.840
|
0.094
| | | |
Hemoglobin level
|
≤ 100/> 100
|
1.596
|
0.542–4.701
|
0.396
| | | |
Tumor location
|
Proximal, middle/Distal
|
1.305
|
0.572–2.981
|
0.527
| | | |
TNM stage (AJCC classification)
|
III, IV/ I, II
|
6.627
|
2.640–16.638
|
0.000*
|
4.218
|
1.560–11.407
|
0.005*
|
Chemotherapy
|
Yes/No
|
1.318
|
0.573–3.034
|
0.516
| | | |
Lymphadenectomy type
|
D1/D1+/D2
|
3.490
|
1.308–9.311
|
0.013*
|
4.353
|
1.511–12.541
|
0.006*
|
Gastrectomy type
|
Total/Partial
|
2.577
|
1.074–6.184
|
0.034*
|
2.883
|
0.846–9.829
|
0.091
|
aOverall complication
|
Yes/No
|
4.480
|
1.901–10.560
|
0.001*
|
3.849
|
1.342–11.040
|
0.012*
|
- *p < 0.05
- aOverall complication is defined as Clavien-Dindo ≥ grade II